Mutation Status and Prognostic Value of KRAS and BRAF in Southeast Iranian Colorectal Cancer Patients: First Report from Southeast of Iran

被引:0
|
作者
Abolfazl Yari
Arash Samoudi
Asiyeh Afzali
Zahra Miri Karam
Negin Khaje Karimaldini
Maryam Fekri Soofi Abadi
Mahsa Ziasistani
Mohammad Reza Zangouey
Shahriar Dabiri
机构
[1] Kerman University of Medical Sciences,Student Research Committee
[2] Kerman University of Medical Sciences,Department of Pathology, Pathology and Stem Cell Research Center, Afzalipour School of Medicine
[3] Kerman University of Medical Sciences,Department of Immunology, Afzalipour School of Medicine
[4] Iran University of Medical Sciences,Department of Medical Laboratory of Sciences
[5] Kerman University of Medical Sciences,Physiology Research Center
来源
关键词
KRAS; BRAF; Overall survival; Clinicopathological features; Colorectal cancer; Southeast Iranian;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:557 / 568
页数:11
相关论文
共 50 条
  • [21] Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
    Fang Guo
    Hai Gong
    Huanhuan Zhao
    Jing Chen
    Yiming Zhang
    Lihua Zhang
    Xin Shi
    Aifeng Zhang
    Hui Jin
    Jianqiong Zhang
    Youji He
    Scientific Reports, 8
  • [22] The prognostic utilities of DNA mismatch repair status and KRAS and BRAF mutation in Korean colorectal cancer patients: The KASID multicenter study
    Kim, Tae-Woo
    Hwang, Soon Woo
    Kim, Kyeong Ok
    Cha, Jae Myung
    Joo, Young-Eun
    Cho, Young-Seok
    ONCOLOGY, 2023, 101 (01) : 49 - 58
  • [23] Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
    Guo, Fang
    Gong, Hai
    Zhao, Huanhuan
    Chen, Jing
    Zhang, Yiming
    Zhang, Lihua
    Shi, Xin
    Zhang, Aifeng
    Jin, Hui
    Zhang, Jianqiong
    He, Youji
    SCIENTIFIC REPORTS, 2018, 8
  • [24] Stratification of patients by specific KRAS gene mutation and BRAF gene status leads to significant differential prognostic effects in colorectal cancer
    Lugli, Alessandro
    Bihl, Michel
    Rufle, Alexander
    Foerster, Anja
    Terracciano, Luigi
    Heinimann, Karl
    Zlobec, Inti
    CANCER RESEARCH, 2009, 69
  • [25] Stratification of patients by specific KRAS gene mutation and BRAF gene status leads to significant differential prognostic effects in colorectal cancer
    Lugli, Alessandro
    Bihl, Michel
    Rufle, Alexander
    Forster, Anja
    Terracciano, Luigi
    Heinimann, Karl
    Zlobec, Intl
    CANCER RESEARCH, 2009, 69
  • [26] KRAS and BRAF mutations in colorectal cancer patients in northwest of Iran.
    Dolatkhah, Roya
    Dastgiri, Saeed
    Somi, Mohammad Hossein
    Bonyadi, Morteza Jabbarpour
    Kermani, Iraj Asvadi
    Farassati, Faris
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] MUTATION PATTERN OF KRAS AND BRAF ONCOGENES IN COLORECTAL CANCER PATIENTS OF CROATIA
    Rako, I.
    Razumovic, J. J.
    Caban, D.
    Sertic, J.
    Plestina, S.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S611 - S611
  • [28] KRAS and BRAF mutation frequencies in a series of Turkish colorectal cancer patients
    Baskin, Yasemin
    Calibasi, Gizem
    Amirfallah, Arsalan
    Dagdeviren, Yusuf Kagan
    Canda, Aras Emre
    Sarioglu, Sulen
    Sagol, Ozgul
    Ellidokuz, Hulya
    Oztop, Ilhan
    Yilmaz, Ugur
    TRANSLATIONAL CANCER RESEARCH, 2014, 3 (02) : 160 - 166
  • [29] Prognostic relevance of KRAS and BRAF mutations in Japanese patients with colorectal cancer
    Nakanishi, Ryota
    Harada, Jun
    Tuul, Munkhbold
    Zhao, Yan
    Ando, Koji
    Saeki, Hiroshi
    Oki, Eiji
    Ohga, Takefumi
    Kitao, Hiroyuki
    Kakeji, Yoshihiro
    Maehara, Yoshihiko
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2013, 18 (06) : 1042 - 1048
  • [30] Prognostic significance of KRAS and BRAF mutations in Japanese patients with colorectal cancer
    Oki, Eiji
    Nakanishi, Ryota
    Ando, Koji
    Saeki, Hiroshi
    Ohga, Takefumi
    Kakeji, Yoshihiro
    Tsujitani, Shunichi
    Kohnoe, Shunji
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)